Bradley Wayne Patterson, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1553 W Collin Raye Dr, De Queen, AR 71832 Phone: 870-584-3000 Fax: 870-584-3003 |
Katy Ann Moss, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 500 E Collin Raye Dr, De Queen, AR 71832 Phone: 870-584-1053 Fax: 870-584-2087 |
Mrs. Tawnya Lee Lansdell, APRN-CNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 500 E Collin Raye Dr, De Queen, AR 71832 Phone: 870-642-7257 Fax: 870-642-5015 |
Ladonna Batty, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1357 W Collin Raye Dr, De Queen, AR 71832 Phone: 870-642-2000 Fax: 870-642-2005 |
News Archive
Is it possible to prevent the development of schizophrenia? Can certain patients develop autism if they carry a specific gene and have been exposed to a viral fetal infection? Should all ADHD patients take the same type of medication? This unique research project will try to answer these questions. The project is based at Aarhus University and will be known as 'The Lundbeck Foundation's Initiative for Integrative Psychiatric Research.'
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported today at an international research meeting in Fort Lauderdale, Florida. The findings will also appear online shortly in the leading journal Ophthalmology.
To reduce maternal and neo-natal deaths, India launched a cash transfer programme in 2005 that provides monetary incentives for women to give birth in health facilities instead of at home. While the programme successfully increased the use of health facilities for child birth, it did not reduce maternal deaths as much, especially in poor areas.
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.
Alkermes, Inc. and Acceleron Pharma, Inc. today announced that Alkermes has licensed a proprietary long-acting Fc fusion technology platform, called the Medifusion™ technology, which is designed to extend the circulating half-life of proteins and peptides.
› Verified 9 days ago